glp-1 in type 2 diabetes Clinical Focus on Agonists Mellitus GLP-1 receptor agonists in the

& Theodoly, O

Without systematic tracking, you may either stop treatment too early (missing additional benefits) or continue too long at a dose that is not working

When Another App May Be Better Choose Medisafe or MyTherapy if your need is generic medication reminders unrelated to GLP-1 pill bottles, multi-medication schedules across unrelated drugs, or vitamin reminders

Data show that in adult patients with type 2 diabetes with increased cardiovascular (CV) risk, compared with titrated insulin glargine, all three doses of tirzepatide show superiority in reducing blood sugar and body weight: treatment for 52 weeks, with curative effect Estimation (efficacy estimand) statistical analysis method, the highest dose of tirzepatide (15 mg, once a week) reduces blood glucose level (A1C) from baseline by 2.58%, and weight from baseline by 11.7 kg (25.8 pounds, 13.0%), and titration Insulin glargine reduced A1C from baseline by 1.44% and body weight increased by 1.9 kg (4.2 lbs, 2.2%) from baseline

doi: 10.1371/journal.pone.0087716 10 TseliosKKoumarasCUrowitzMBGladmanDD